Cite
HARVARD Citation
Grecea, M. et al. (2020). Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death‐Ligand 1 Blockade: A Case Discussion and Review of the Literature. Oncologist. pp. 369-374. [Online].